title: Increased skeletal muscle Na+, K+-ATPase activity as a cause of increased lactate production after hemorrhagic shock.
abstract: BACKGROUND
  Lactate production after hemorrhagic shock may be produced by aerobic glycolysis, which has been linked to activity of the Na+/K+ pump in smooth muscle and other tissues. We tested whether increased muscle Na+/K+ pump activity after shock was linked to increased lactate production.
  
  
  METHODS
  Male Sprague-Dawley rats were subjected to 1 or 2 hours of hemorrhagic shock and then resuscitated with shed blood and normal saline. After 24 hours, pairs of extensor digitorum longus muscles were preincubated for 30 minutes in Krebs buffer (95:5, O2:CO2) with 10 mmol/L glucose. One muscle served as a control and was incubated in buffer alone; the other was incubated in buffer with 1 mmol/L ouabain, an inhibitor of the Na+, K+-ATPase. Lactate, ADP, ATP, glycogen, and creatinine-phosphate were determined.
  
  
  RESULTS
  Under these well-oxygenated conditions, muscles from shocked rats produced about twice as much lactate as sham muscles. Inhibition of the Na+/K+ pump by ouabain significantly reduced lactate production.
  
  
  CONCLUSIONS
  Hypoxia is unlikely to account for increased muscle lactate production after resuscitated hemorrhagic shock, because high lactate production persists under well-oxygenated incubation conditions. Inhibition of shock-induced lactate production by ouabain indicates energetic coupling of glycolysis to the Na+, K+-ATPase.
authors.affiliation: Department of Surgery, University of Cincinnati College of Medicine, Ohio, USA. fred.luchette@uc.edu
authors.forename: F A
authors.initials: FA
authors.lastname: Luchette
authors.forename: L A
authors.initials: LA
authors.lastname: Friend
authors.forename: C C
authors.initials: CC
authors.lastname: Brown
authors.forename: R K
authors.initials: RK
authors.lastname: Upputuri
authors.forename: J H
authors.initials: JH
authors.lastname: James
mesh_terms: D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006003:Glycogen / Q000378:metabolism; D019344:Lactic Acid / Q000096:biosynthesis*; D008297:Male; D018482:Muscle, Skeletal / Q000201:enzymology*; D009924:Organ Culture Techniques; D010042:Ouabain / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012771:Shock, Hemorrhagic / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D019344:Lactic Acid; D010042:Ouabain; D006003:Glycogen; D000254:Sodium-Potassium-Exchanging ATPase